Medical Disclaimer This content is for educational purposes only and is not intended as medical advice, diagnosis, or treatment
Experiences from peptide receptor radionuclide therapy (PRRT), where diagnostic and therapeutic pairs such as 68 Ga/ 177 Lu-DOTA-exendin are co-developed, may offer valuable insights for designing biomarker-guided clinical trials in GLP-1R-targeted nanomedicine
Presented for research literature review only Lakshmikuttyamma A et al
Regular physical activity, particularly resistance training and moderate-to-vigorous exercise, may enhance GLP-1 levels and improve metabolic health
A part of Watch Medier Senior Safety Manager Medical Writer responsible for Clinical Disclosure Pharmacokineticist, PK/PD Modelling & Simulation Global Clinical Lead, Clinical Development, Migraine & Pain Senior Medical Specialist, Therapeutic Areas - Global Clinical Development Rdgiver og forhandler med flair for pipeline og partnerskaber (Pipeline Insights & Engagement Advisor) - vil du vre med til at sikre fremtidens adgang til nye lgemidler
Phase 2: Larger trials measure weight loss and side effects